Marked hypertriglyceridemia upon treatment with etanercept.
Haroon
Muhammad
M
Devlin
Joe
J
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D000068800:Etanercept; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D008075:Lipoproteins, HDL; D018124:Receptors, Tumor Necrosis Factor; D014280:Triglycerides; D002784:Cholesterol; D000068800:Etanercept; D008727:Methotrexate